TNFα altered inflammatory responses, impaired health and productivity, but did not affect glucose or lipid metabolism in early-lactation dairy cows

dc.citation.doidoi:10.1371/journal.pone.0080316en_US
dc.citation.issue11en_US
dc.citation.jtitlePLoS ONEen_US
dc.citation.spagee80316en_US
dc.citation.volume8en_US
dc.contributor.authorYuan, Kai
dc.contributor.authorFarney, Jaymelynn K.
dc.contributor.authorMamedova, Laman K.
dc.contributor.authorSordillo, Lorraine M.
dc.contributor.authorBradford, Barry J.
dc.contributor.authoreidjkjen_US
dc.contributor.authoreidmamedovaen_US
dc.contributor.authoreidbbradforen_US
dc.date.accessioned2014-03-05T22:21:54Z
dc.date.available2014-03-05T22:21:54Z
dc.date.issued2014-03-05
dc.date.published2013en_US
dc.description.abstractInflammation may be a major contributing factor to peripartum metabolic disorders in dairy cattle. We tested whether administering an inflammatory cytokine, recombinant bovine tumor necrosis factor-α (rbTNFα), affects milk production, metabolism, and health during this period. Thirty-three Holstein cows (9 primiparous and 24 multiparous) were randomly assigned to 1 of 3 treatments at parturition. Treatments were 0 (Control), 1.5, or 3.0 µg/kg body weight rbTNFα, which were administered once daily by subcutaneous injection for the first 7 days of lactation. Statistical contrasts were used to evaluate the treatment and dose effects of rbTNFα administration. Plasma TNFα concentrations at 16 h post-administration tended to be increased (P<0.10) by rbTNFα administration, but no dose effect (P>0.10) was detected; rbTNFα treatments increased (P<0.01) concentrations of plasma haptoglobin. Most plasma eicosanoids were not affected (P>0.10) by rbTNFα administration, but 6 out of 16 measured eicosanoids changed (P<0.05) over the first week of lactation, reflecting elevated inflammatory mediators in the days immediately following parturition. Dry matter and water intake, milk yield, and milk fat and protein yields were all decreased (P<0.05) by rbTNFα treatments by 15 to 18%. Concentrations of plasma glucose, insulin, β-hydroxybutyrate, non-esterified fatty acids, triglyceride, 3-methylhistidine, and liver triglyceride were unaffected (P>0.10) by rbTNFα treatment. Glucose turnover rate was unaffected (P = 0.18) by rbTNFα administration. The higher dose of rbTNFα tended to increase the risk of cows developing one or more health disorders (P = 0.08). Taken together, these results indicate that administration of rbTNFα daily for the first 7 days of lactation altered inflammatory responses, impaired milk production and health, but did not significantly affect liver triglyceride accumulation or nutrient metabolism in dairy cows.en_US
dc.identifier.urihttp://hdl.handle.net/2097/17204
dc.language.isoen_USen_US
dc.relation.urihttp://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080316en_US
dc.subjectInflammationen_US
dc.subjectDairy cattleen_US
dc.subjectPeripartum metabolic disordersen_US
dc.subjectMilk productionen_US
dc.titleTNFα altered inflammatory responses, impaired health and productivity, but did not affect glucose or lipid metabolism in early-lactation dairy cowsen_US
dc.typeArticle (publisher version)en_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
BradfordPLOS2013.pdf
Size:
322.44 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.62 KB
Format:
Item-specific license agreed upon to submission
Description: